Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly

BACKGROUND: An essential criterion for control of acromegaly is normalization of IGF-I levels. Somatostatin analogues act to suppress IGF-I and GH levels. OBJECTIVE: To assess the efficacy and safety of 48 weeks titrated dosing of lanreotide Autogel. DESIGN: Open-label, multicentre, phase III, 48-we...

Descripción completa

Detalles Bibliográficos
Autores principales: Chanson, Philippe, Borson-Chazot, Françoise, Kuhn, Jean-Marc, Blumberg, Joëlle, Maisonobe, Pascal, Delemer, Brigitte
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610402/
https://www.ncbi.nlm.nih.gov/pubmed/18248639
http://dx.doi.org/10.1111/j.1365-2265.2008.03208.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610402/
https://www.ncbi.nlm.nih.gov/pubmed/18248639
http://dx.doi.org/10.1111/j.1365-2265.2008.03208.x

Ejemplares similares